Sign in
4

Changes in Ownership

CG Oncology, Inc. Filed Acc 0000950170-25-005359

Director sold 1,000 shares at $29.66 ($29,660)

  • Director acquired 1,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
POST LEONARD E Director 2025-01-13 Option exercise 10b5-1 +1,000 $0.60 $600 1,000 D: show line 1 in the form
POST LEONARD E Director 2025-01-13 Sale 10b5-1 −1,000 $29.66 $29,660 0 D: show line 2 in the form
Open-market sales · 1,000 sh · avg $29.66 · $29,660

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
POST LEONARD E Director 2025-01-13 Option exercise · Director Stock Option (right to buy) 10b5-1 −1,000 132,077 D: show line 3 in the form
Loading xslF345X05/ownership.xml…